Phase I trial of valaciclovir, the L-valyl ester of acyclovir, in patients with advanced human immunodeficiency virus disease.

Valaciclovir, the L-valyl ester of acyclovir, is rapidly and extensively converted in humans to acyclovir after oral administration by first-pass metabolism. A phase I study was conducted in two cohorts of volunteers with advanced human immunodeficiency virus (HIV) disease (absolute CD4 lymphocyte c...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Antimicrob Agents Chemother
Main Authors: Jacobson, M A, Gallant, J, Wang, L H, Coakley, D, Weller, S, Gary, D, Squires, L, Smiley, M L, Blum, M R, Feinberg, J
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology (ASM) 1994
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284589/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7979285/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.7.1534
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki